Israeli Startup Combines Software With Medicine To Transform $1.6 Trillion Pharma Market [Forbes]
Kaltura, Inc. (KLTR)
Company Research
Source: Forbes
Combining software with medicine to unlock an entire new market for “hybrid drugs” is the vision driving Israeli startup . As many diseases are better treated by combining drugs with non-pharmacological interventions, Remepy is making such combinations standardized, accessible and personalized at scale with the use of its “digital molecules.” These are digitized, evidence-based therapeutic interventions that trigger physiological effects that have been known to enhance the effectiveness of traditional drugs. Michal Tsur, Remepy co-founder and co-CEO, calls its hybrid approach “a very big revolution, similar to what happened with immunotherapy,” which transformed the world of pharma by harnessing the immune system to attack tumors. “We are using digital tools in order to harness the brain to drive physiological effects that are synergistic with drugs,” explains Tsur. Remepy announced last month that it has successfully closed a $10 million seed investment round, which together wit
Show less
Read more
Impact Snapshot
Event Time:
KLTR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
KLTR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
KLTR alerts
High impacting Kaltura, Inc. news events
Weekly update
A roundup of the hottest topics
KLTR
News
- Kaltura, Inc. (NASDAQ: KLTR) had its price target lowered by analysts at Wells Fargo & Company from $1.50 to $1.00. They now have an "underweight" rating on the stock.MarketBeat
- Kaltura Takes Home Four Awards at Eventex 2024 Including Best Event Technology and Best Virtual Event Platform [Yahoo! Finance]Yahoo! Finance
- Kaltura Wins Best Virtual and Hybrid Event Platform at the 2024 Event Technology Awards [Yahoo! Finance]Yahoo! Finance
- Kaltura Announces Stock Repurchase Program [Yahoo! Finance]Yahoo! Finance
- Kaltura Announces Stock Repurchase ProgramGlobeNewswire
KLTR
Earnings
- 5/8/24 - Beat
KLTR
Sec Filings
- 6/21/24 - Form 4
- 6/21/24 - Form 4
- 6/21/24 - Form 4
- KLTR's page on the SEC website